Abstract
Peptide therapeutics hold great promise for the treatment of cancer due to low toxicity, high specificity, and ease of synthesis and modification. However, the unfavorable pharmacokinetic parameters strictly limit their therapeutic efficacy and clinical translation. Here, we tailor-designed an amphiphilic chimeric peptide through conjugation of functional 3-diethylaminopropyl isothiocyanate (DEAP) molecules to a short antitumor peptide, C16Y. The ultimate DEAP-C16Y peptides self-assembled into spherical nanostructures at physiologic conditions, which dissociated to release individual peptide molecules in weakly acidic tumors. DEAP-C16Y peptides showed negligible cytotoxicity but impaired vascular endothelial cell migration and tubule formation by inactivation of the focal adhesion kinase and PI3K-Akt pathways, as well as tumor cell invasion by decreasing invadopodia formation. Compared with C16Y, the systemically administered DEAP-C16Y nanostructures exhibited superior stability, thereby allowing prolonged treatment interval and resulting in significant decreases in microvessel density, tumor growth, and distant metastasis formation in orthotopic mammary tumor models. Through encapsulation of hydrophobic doxorubicin, DEAP-C16Y nanostructure served as a smart carrier to achieve targeted drug delivery and combination therapy. Our study, for the first time, demonstrates that a simple nanoformulation using a functional antitumor peptide as the building block can show innate antitumor activity and also provide a nanoplatform for combination therapy, opening a new avenue for the design of antitumor nanotherapeutics.
Highlights
Angiogenesis and metastasis are two essential hallmarks of cancer [1]
transmission electron microscopy (TEM) examination showed that diethylaminopropyl isothiocyanate (DEAP)–C16Y (1 mg/mL) formed spherical nanostructures at pH 7.4, which turned to a disassembled state when the pH was adjusted to 6.8
These results demonstrated that DEAP–C16Y can self-assemble into a regular nanostructure at physiologic pH, which dissociated in weakly acidic environment
Summary
Angiogenesis and metastasis are two essential hallmarks of cancer [1]. Receptors, and extracellular matrix (ECM) components coordinate to induce tumor vessel sprouting for sustained neoplastic growth [2]. Tumor neovasculature provides a primary pathway for tumor cell dissemination that depends on the invasive capability of tumor cells. Therapeutic targeting of tumor angiogenesis and tumor cell invasion shows great potential for preventing cancer progression [3, 4]. Bioactive peptides are promising therapeutic agents due to low toxicity, high specificity, high tissue penetration, and ease of synthesis and modification [5, 6]. Multiple antitumor peptides have been identified, mostly derived from natural proteins [7, 8]. A peptide that competes for laminin-1 binding, C16Y
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
